chr12-6377490-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001270987.2(LTBR):c.39+1896T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 661,246 control chromosomes in the GnomAD database, including 14,212 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2680 hom., cov: 32)
Exomes 𝑓: 0.20 ( 11532 hom. )
Consequence
LTBR
NM_001270987.2 intron
NM_001270987.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.223
Genes affected
LTBR (HGNC:6718): (lymphotoxin beta receptor) This gene encodes a member of the tumor necrosis factor receptor superfamily. The major ligands of this receptor include lymphotoxin alpha/beta and tumor necrosis factor ligand superfamily member 14. The encoded protein plays a role in signalling during the development of lymphoid and other organs, lipid metabolism, immune response, and programmed cell death. Activity of this receptor has also been linked to carcinogenesis. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2012]
SCNN1A (HGNC:10599): (sodium channel epithelial 1 subunit alpha) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the alpha subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 12-6377490-T-C is Benign according to our data. Variant chr12-6377490-T-C is described in ClinVar as [Benign]. Clinvar id is 1242331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBR | NM_001270987.2 | c.39+1896T>C | intron_variant | Intron 1 of 9 | NP_001257916.1 | |||
LTBR | NM_001414309.1 | c.39+1896T>C | intron_variant | Intron 1 of 9 | NP_001401238.1 | |||
SCNN1A | NM_001159575.2 | c.-224A>G | upstream_gene_variant | NP_001153047.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBR | ENST00000539925.5 | c.39+1896T>C | intron_variant | Intron 1 of 9 | 2 | ENSP00000440875.1 | ||||
SCNN1A | ENST00000536788.1 | c.9+177A>G | intron_variant | Intron 1 of 1 | 4 | ENSP00000443434.1 | ||||
SCNN1A | ENST00000538957.1 | n.23-139A>G | intron_variant | Intron 1 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.175 AC: 26592AN: 152056Hom.: 2681 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
26592
AN:
152056
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.203 AC: 103365AN: 509072Hom.: 11532 AF XY: 0.204 AC XY: 54478AN XY: 267230 show subpopulations
GnomAD4 exome
AF:
AC:
103365
AN:
509072
Hom.:
AF XY:
AC XY:
54478
AN XY:
267230
Gnomad4 AFR exome
AF:
AC:
1308
AN:
13750
Gnomad4 AMR exome
AF:
AC:
3449
AN:
22896
Gnomad4 ASJ exome
AF:
AC:
1800
AN:
14622
Gnomad4 EAS exome
AF:
AC:
1937
AN:
29852
Gnomad4 SAS exome
AF:
AC:
11280
AN:
50354
Gnomad4 FIN exome
AF:
AC:
7277
AN:
27878
Gnomad4 NFE exome
AF:
AC:
71240
AN:
320178
Gnomad4 Remaining exome
AF:
AC:
4864
AN:
27438
Heterozygous variant carriers
0
3897
7795
11692
15590
19487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.175 AC: 26605AN: 152174Hom.: 2680 Cov.: 32 AF XY: 0.176 AC XY: 13105AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
26605
AN:
152174
Hom.:
Cov.:
32
AF XY:
AC XY:
13105
AN XY:
74412
Gnomad4 AFR
AF:
AC:
0.0965994
AN:
0.0965994
Gnomad4 AMR
AF:
AC:
0.148017
AN:
0.148017
Gnomad4 ASJ
AF:
AC:
0.135104
AN:
0.135104
Gnomad4 EAS
AF:
AC:
0.0735747
AN:
0.0735747
Gnomad4 SAS
AF:
AC:
0.227367
AN:
0.227367
Gnomad4 FIN
AF:
AC:
0.264167
AN:
0.264167
Gnomad4 NFE
AF:
AC:
0.220417
AN:
0.220417
Gnomad4 OTH
AF:
AC:
0.14218
AN:
0.14218
Heterozygous variant carriers
0
1113
2226
3339
4452
5565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
474
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at